Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir

BACKGROUND: Data about adverse events are needed to optimise telaprevir-based therapy in a broad spectrum of patients. AIM: To investigate adverse events of telaprevir-based therapy in patients with and without advanced fibrosis or cirrhosis in a real-world setting. METHODS: Data on 174 hepatitis C-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bichoupan, K., Schwartz, J. M., Martel-Laferriere, V., Giannattasio, E. R., Marfo, K., Odin, J. A., Liu, L. U., Schiano, T. D., Perumalswami, P., Bansal, M., Gaglio, P. J., Kalia, H., Dieterich, D. T., Branch, A. D., Reinus, J. F.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4141692/
https://ncbi.nlm.nih.gov/pubmed/24266536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.12560
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares